Efficacy and safety of tranexamic acid on blood loss and seizures in patients undergoing meningioma resection: A systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308070 ↗Kurz gefasst
Metaanalyse in der Zeitschrift PLOS ONE, 2024. Verfasst von Xiaoyuan Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Meningioma, Tranexamic Acid, Seizures, Blood Loss, Surgical. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Municipal Science and Technology Commission, Beijing Municipal Administration of Hospitals Incubating Program, Beijing Municipal Administration of Hospitals’ Youth Program.
Abstract (Originalsprache)
Introduction
It is unclear how tranexamic acid (TXA) affects blood loss and seizures in meningioma resections. We performed a systematic review and meta-analysis and tried to evaluate the effectiveness and safety of TXA use for patients undergoing meningioma resections.
Methods
Regards to this systematic review and meta-analysis (registered with CRD42023416693), we searched PubMed, Embase (Ovid), EBSCO, and Cochrane central library up to and including Oct 2023. Patients undergoing meningioma resections treated with TXA and placebo or no treatment were eligible for this study. This would allow delineation of the impact of TXA on blood loss, postoperative seizure, and other complication incidences.
Results
Four prospective cohort studies with 781 patients (390 patients in the TXA group and 391 patients in the control group) were conducted via a systematic review and meta-analysis. The results suggested that the application of TXA for patients undergoing meningioma resections reduced mean blood loss of 252 mL with 95% confidence interval (CI) -469.26 to -34.67 (P = 0.02) and I 2 of 94% but did not increase postoperative seizure (risk ratio: 1.08; 95%CI: 0.54 to 2.15; P = 0.84) and other complication rates.
Conclusions
This systematic review and meta-analysis suggests that the administration of TXA could reduce blood loss in patients undergoing intracerebral meningioma resection. Registry information The systematic review protocol has been registered at PROSPERO (Registration No. CRD42023416693 ) on April 23, 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Outcomes Research Consortium, Cleveland, Ohio, United States of America.
ORCID-Profile: Yuming Peng
Förderung
- Beijing Municipal Science and Technology Commission
- Beijing Municipal Administration of Hospitals Incubating Program
- Beijing Municipal Administration of Hospitals’ Youth Program
Zitieren
APA
Liu, X., Liu, M., Li, S., Ren, Y., Zheng, M., Zeng, M., & Peng, Y. (2024). Efficacy and safety of tranexamic acid on blood loss and seizures in patients undergoing meningioma resection: A systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0308070
Vancouver
Liu X, Liu M, Li S, Ren Y, Zheng M, Zeng M, et al. Efficacy and safety of tranexamic acid on blood loss and seizures in patients undergoing meningioma resection: A systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0308070
BibTeX
@article{Liu2024,
author = {Liu, Xiaoyuan and Liu, Minying and Li, Shu and Ren, Yue and Zheng, Maoyao and Zeng, Min and Peng, Yuming},
title = {Efficacy and safety of tranexamic acid on blood loss and seizures in patients undergoing meningioma resection: A systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308070}
}
EUVIMED